NCT02099149View on ClinicalTrials.gov

Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Infants Aged Less Than 90 Days

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

May 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Invasive Group B Streptococcus Disease
Trial Locations (1)

2013

Respiratory and Meningeal Pathogen Research Unit, Soweto

Sponsors

Lead Sponsor

Novartis

Collaborators (1)

Novartis Vaccines
All Listed Sponsors
collaborator

Novartis Vaccines

INDUSTRY

lead

Novartis

INDUSTRY